
1. Nat Microbiol. 2020 May;5(5):735-745. doi: 10.1038/s41564-020-0676-2. Epub 2020
Apr 27.

Niche specialization and spread of Staphylococcus capitis involved in neonatal
sepsis.

Wirth T(1)(2), Bergot M(3), Rasigade JP(4)(3)(5), Pichon B(6), Barbier M(4),
Martins-Simoes P(3)(5), Jacob L(7), Pike R(6), Tissieres P(8)(9), Picaud JC(10), 
Kearns A(6), Supply P(11), Butin M(12)(13), Laurent F(3)(5); International
Consortium for Staphylococcus capitis neonatal sepsis; ESGS Study Group of
ESCMID.

Collaborators: Adamkova V, Barkham T, Becker K, Bennett D, Claris O, Creech CB,
De Lencastre H, Deighton M, Denis O, Ferguson J, Huang YC, Klingenberg C,
Ingebretsen A, Laferrière C, Dos Santos KRN, Schrenzel J, Spiliopoulou I, Stefani
S, TaekSoo K, Tarkka E, Friedrich A, Vandenbroucke-Grauls C, Ussher J, Vandenesch
F, Westblade L, Lindsay J, Vandenesch F, Larsen AR, Zanger P, Kahl BC, Aymerich
CP.

Author information: 
(1)Institut Systématique Evolution Biodiversité (ISYEB), Muséum national
d'Histoire naturelle, CNRS, Sorbonne Université, Université des Antilles, EPHE,
Paris, France. wirth@mnhn.fr.
(2)PSL University, EPHE, Paris, France. wirth@mnhn.fr.
(3)Institut des Agents Infectieux, Département de Bactériologie, Centre National 
de Référence des Staphylocoques, Hospices Civils de Lyon, Lyon, France.
(4)Institut Systématique Evolution Biodiversité (ISYEB), Muséum national
d'Histoire naturelle, CNRS, Sorbonne Université, Université des Antilles, EPHE,
Paris, France.
(5)Centre International de recherche en Infectiologie, INSERM U1111 - CNRS
UMR5308 - ENS Lyon - Université Lyon 1, Lyon, France.
(6)Staphylococcus Reference Section, National Infection Service, Public Health
England, London, UK.
(7)Laboratoire Biométrie et Biologie Evolutive, CNRS UMR5558, Université Lyon 1, 
Lyon, France.
(8)Institut de Biologie de la cellule (I2BC-UMR9198), CNRS, CEA, Univ. Paris Sud,
Université Paris Saclay, Gif-sur-Yvette, France.
(9)Service de Réanimation Néonatale, Hôpitaux Universitaires Paris Sud APHP, Le
Kremlin-Bicêtre, Paris, France.
(10)Service de Réanimation Néonatale, Hôpital Croix Rousse, Hospices Civils de
Lyon, Lyon, France.
(11)Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille,
U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille,
France.
(12)Centre International de recherche en Infectiologie, INSERM U1111 - CNRS
UMR5308 - ENS Lyon - Université Lyon 1, Lyon, France. marine.butin@chu-lyon.fr.
(13)Service de Réanimation Néonatale, Hôpital Femme Mère Enfant, Hospices Civils 
de Lyon, Lyon, France. marine.butin@chu-lyon.fr.

The multidrug-resistant Staphylococcus capitis NRCS-A clone is responsible for
sepsis in preterm infants in neonatal intensive care units (NICUs) worldwide.
Here, to retrace the spread of this clone and to identify drivers of its specific
success, we investigated a representative collection of 250 S. capitis isolates
from adults and newborns. Bayesian analyses confirmed the spread of the NRCS-A
clone and enabled us to date its emergence in the late 1960s and its expansion
during the 1980s, coinciding with the establishment of NICUs and the increasing
use of vancomycin in these units, respectively. This dynamic was accompanied by
the acquisition of mutations in antimicrobial resistance- and
bacteriocin-encoding genes. Furthermore, combined statistical tools and a
genome-wide association study convergently point to vancomycin resistance as a
major driver of NRCS-A success. We also identified another S. capitis subclade
(alpha clade) that emerged independently, showing parallel evolution towards NICU
specialization and non-susceptibility to vancomycin, indicating convergent
evolution in NICU-associated pathogens. These findings illustrate how the broad
use of antibiotics can repeatedly lead initially commensal drug-susceptible
bacteria to evolve into multidrug-resistant clones that are able to successfully 
spread worldwide and become pathogenic for highly vulnerable patients.

DOI: 10.1038/s41564-020-0676-2 
PMID: 32341568  [Indexed for MEDLINE]

